Vivian Lee-Kimمشاهده پروفایل
استادیار
Vivian Lee-Kim is an Assistant Professor in the Department of Pediatrics, Division of Cardiology at The University of Texas Southwestern Medical Center, with a secondary appointment in the Department of Molecular Biology. She is also a member of the Center for Regenerative Science and Medicine. Education B.S. in Biochemistry, University of Washington Ph.D. in Developmental, Regenerative, and Stem Cell Biology, Washington University in St. Louis Postdoctoral Fellow, Brigham and Women's Hospital and Harvard Medical School Research Interests Dr. Lee-Kim's research focuses on the genetic and molecular mechanisms of cardiovascular diseases, particularly thoracic aortic aneurysms and coronary artery disease. She employs genomic approaches, CRISPR-based genome editing, and vascular biology to dissect disease pathways and identify therapeutic targets. Her work bridges basic science with clinical applications in regenerative medicine, investigating coding and noncoding genetic variations that contribute to vascular pathologies. Recent Research Trends Analysis of Dr. Lee-Kim's 13 publications (2012-2024) reveals an evolution from extracellular matrix genetics in aortic aneurysms to cutting-edge multi-omics studies of coronary artery disease. Her recent work (2020-2024) emphasizes endothelial cell programs, CRISPR perturbation screens, and functional genomics to identify novel therapeutic targets, while earlier research (2012-2016) explored mechanisms of aortic dilation and lung injury models. This trajectory demonstrates increasing integration of genomic technologies with vascular pathophysiology. Honors & Awards No specific awards are listed in the available information. Advising and Grants Information regarding student mentorship, grant funding, or research funding sources is not provided in the available text. Labs and Teams Dr. Lee-Kim is an active member of the Center for Regenerative Science and Medicine at UT Southwestern, which fosters interdisciplinary collaboration in tissue engineering, stem cell therapies, and vascular regeneration research.








